Laden…
Synapedia is an independent knowledge project about psychoactive substances and harm reduction. If the platform helps you learn something new, you can support its development.
Every bit helps keep the project alive.
1-(1-benzofuran-5-yl)-N-methylpropan-2-amine
5-MAPB is a substance from the class of benzofurans. Further information will follow after enrichment.
Translation in progress
This section is currently being translated. Content will be available soon.
View German version →Receptor Targets
Mechanism of Action
5-MAPB acts through the following pharmacological mechanisms:
Designations
IUPAC: [2-(benzofuran-5-yl)-1-methyl-ethyl]-methyl-amine
Legal Status
Legal status not verified by official sources. Please check current legislation independently.
Information without guarantee. Not legal advice.
Effects & Pharmacology — Translation in progress
This section is being translated. Content is available in German.
View in German →Total duration 6-8 hours
Peak
2-3 hours
Onset
30-60 minutes
Total duration
6-8 hours
After effects
2-4 hours
Start low. Individual sensitivity varies.
Dose sensitivity varies greatly between individuals. Body weight, tolerance, route of administration, and pre-existing conditions significantly affect outcomes.
Risks
Summary
Mögliche Nebenwirkungen sind nicht umfassend dokumentiert.
Safer Use
The risks listed may be incomplete. Especially for research chemicals and rare substances, available data is limited.
Some combinations can be dangerous. Research before combining substances.
Serotoninsyndrom: Potentes Benzofuran-Empathogen + SSRI
5-MAPB ist ein potenter Serotoninfreisetzer aus der Benzofuran-Klasse. Das serotoninerge Profil ist ausgeprägter als bei MDMA. Die Kombination mit SSRI kann zu einer unkontrollierten Erhöhung der synaptischen Serotoninkonzentration und einem Serotoninsyndrom führen.
Interaction data is based on known mechanisms. Unknown or rare interactions are possible and may be life-threatening.
Based on substance class, receptors, mechanisms, and effect profile.